MedTrace Logo

Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

NCT02239666 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 899

Last updated 2017-08-03

No results posted yet for this study

Summary

To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.

Conditions

Interventions

OTHER

NIS

This is a non-interventional study (NIS) of usual care over the 12 months following initiation of biologic therapy.

Sponsors & Collaborators

Principal Investigators

  • Edward Hammond · AstraZeneca

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-01
Primary Completion
2017-01-05
Completion
2017-01-05

Countries

  • United States
  • France
  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02239666 on ClinicalTrials.gov